Exosomes isolated from the serum of glioblastoma patients show increased levels of glioblastoma-specific epidermal growth factor receptor (EGFR) vIII, suggesting that it could be used as a diagnostic marker for cancer [201]. This evidence concerns the gene EGFR and cancer.